Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.

BMC Urol · 2014 · PMC3912255 · PMID 24472670

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

But, we cannot rule out the role of growth inhibition of CTCE-9908 in our model as mean tumor growth is inhibited in CTCE-9908 treated group, though the data did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.